Проект на тему



бет4/7
Дата25.01.2022
өлшемі0,97 Mb.
#114289
1   2   3   4   5   6   7
Байланысты:
док мед

In patients, who received pentoxifylline, curvature reduction was 26.7%, plaque size reduction was 30%, the recovery rate of erectile dysfunction was 46.7% and pain reduced was 73.3%. Each of these cases in patients, who used beta-blockers, was 36.7%, 33.3%, 66.7% and 76.6%. In combination therapy, curvature reduction was 36.7%, plaque size reduction was 33.3%, the recovery rate of erectile dysfunction was 86.7% and pain reduced was 80%.

  • In patients, who received pentoxifylline, curvature reduction was 26.7%, plaque size reduction was 30%, the recovery rate of erectile dysfunction was 46.7% and pain reduced was 73.3%. Each of these cases in patients, who used beta-blockers, was 36.7%, 33.3%, 66.7% and 76.6%. In combination therapy, curvature reduction was 36.7%, plaque size reduction was 33.3%, the recovery rate of erectile dysfunction was 86.7% and pain reduced was 80%.
  • У пациентов, получавших пентоксифиллин, снижение кривизны составило 26,7%, уменьшение размера бляшек составило 30%, частота восстановления эректильной дисфункции составила 46,7%, а снижение боли - 73,3%. Каждый из этих случаев у пациентов, которые использовали бета-блокаторы, составлял 36,7%, 33,3%, 66,7% и 76,6%. В комбинированной терапии снижение кривизны составило 36,7%, уменьшение размера бляшек составило 33,3%, частота излечения эректильной дисфункции составила 86,7%, а уменьшение боли составило 80%.
  • In our study there was no significant difference between two groups using verapamil or pentoxifylline, but there was a significant improvement in combination therapy group. Due to our results we propose that combination therapy can improve results and should be considered as a choice in treatment of Peyronie's disease.
  • В нашем исследовании не было существенной разницы между двумя группами, использующими верапамил или пентоксифиллин, но было отмечено значительное улучшение в группе комбинированной терапии. В связи с нашими результатами мы предлагаем комбинированную терапию, которая могла улучшить результаты и должна рассматриваться как выбор в лечении болезни Пейрони.


Достарыңызбен бөлісу:
1   2   3   4   5   6   7




©engime.org 2024
әкімшілігінің қараңыз

    Басты бет